182 related articles for article (PubMed ID: 19779968)
1. Silibinin suppresses spontaneous tumorigenesis in APC min/+ mouse model by modulating beta-catenin pathway.
Rajamanickam S; Kaur M; Velmurugan B; Singh RP; Agarwal R
Pharm Res; 2009 Dec; 26(12):2558-67. PubMed ID: 19779968
[TBL] [Abstract][Full Text] [Related]
2. Silibinin suppresses growth of human colorectal carcinoma SW480 cells in culture and xenograft through down-regulation of beta-catenin-dependent signaling.
Kaur M; Velmurugan B; Tyagi A; Agarwal C; Singh RP; Agarwal R
Neoplasia; 2010 May; 12(5):415-24. PubMed ID: 20454513
[TBL] [Abstract][Full Text] [Related]
3. Chemoprevention of intestinal tumorigenesis in APCmin/+ mice by silibinin.
Rajamanickam S; Velmurugan B; Kaur M; Singh RP; Agarwal R
Cancer Res; 2010 Mar; 70(6):2368-78. PubMed ID: 20215518
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of silibinin against azoxymethane-induced colon tumorigenesis in A/J mice.
Ravichandran K; Velmurugan B; Gu M; Singh RP; Agarwal R
Clin Cancer Res; 2010 Sep; 16(18):4595-606. PubMed ID: 20823143
[TBL] [Abstract][Full Text] [Related]
5. Naringin, a natural dietary compound, prevents intestinal tumorigenesis in Apc (Min/+) mouse model.
Zhang YS; Li Y; Wang Y; Sun SY; Jiang T; Li C; Cui SX; Qu XJ
J Cancer Res Clin Oncol; 2016 May; 142(5):913-25. PubMed ID: 26702935
[TBL] [Abstract][Full Text] [Related]
6. Dietary feeding of grape seed extract prevents intestinal tumorigenesis in APCmin/+ mice.
Velmurugan B; Singh RP; Kaul N; Agarwal R; Agarwal C
Neoplasia; 2010 Jan; 12(1):95-102. PubMed ID: 20072658
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of intestinal adenoma formation in APC(Min/+) mice by Riccardin D, a natural product derived from liverwort plant Dumortiera hirsuta.
Liu HP; Gao ZH; Cui SX; Sun DF; Wang Y; Zhao CR; Lou HX; Qu XJ
PLoS One; 2012; 7(3):e33243. PubMed ID: 22432006
[TBL] [Abstract][Full Text] [Related]
8. Chemoprevention of intestinal adenomatous polyposis by acetyl-11-keto-beta-boswellic acid in APC(Min/+) mice.
Liu HP; Gao ZH; Cui SX; Wang Y; Li BY; Lou HX; Qu XJ
Int J Cancer; 2013 Jun; 132(11):2667-81. PubMed ID: 23132636
[TBL] [Abstract][Full Text] [Related]
9. Rapamycin inhibition of polyposis and progression to dysplasia in a mouse model.
Hardiman KM; Liu J; Feng Y; Greenson JK; Fearon ER
PLoS One; 2014; 9(4):e96023. PubMed ID: 24763434
[TBL] [Abstract][Full Text] [Related]
10. Chemoprevention utility of silibinin and Cdk4 pathway inhibition in Apc(-/+) mice.
Karim BO; Rhee KJ; Liu G; Zheng D; Huso DL
BMC Cancer; 2013 Mar; 13():157. PubMed ID: 23530816
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
[TBL] [Abstract][Full Text] [Related]
12. Silibinin inhibits colorectal cancer growth by inhibiting tumor cell proliferation and angiogenesis.
Singh RP; Gu M; Agarwal R
Cancer Res; 2008 Mar; 68(6):2043-50. PubMed ID: 18339887
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of azoxymethane-induced colonic aberrant crypt foci formation by silibinin in male Fisher 344 rats.
Velmurugan B; Singh RP; Tyagi A; Agarwal R
Cancer Prev Res (Phila); 2008 Oct; 1(5):376-84. PubMed ID: 19138982
[TBL] [Abstract][Full Text] [Related]
14. Response of Apc(min) and A33 (delta N beta-cat) mutant mice to treatment with tea, sulindac, and 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP).
Orner GA; Dashwood WM; Blum CA; Díaz GD; Li Q; Al-Fageeh M; Tebbutt N; Heath JK; Ernst M; Dashwood RH
Mutat Res; 2002 Sep; 506-507():121-7. PubMed ID: 12351151
[TBL] [Abstract][Full Text] [Related]
15. Olfactomedin 4 deletion induces colon adenocarcinoma in Apc
Liu W; Li H; Hong SH; Piszczek GP; Chen W; Rodgers GP
Oncogene; 2016 Oct; 35(40):5237-5247. PubMed ID: 26973250
[TBL] [Abstract][Full Text] [Related]
16. Silymarin, boswellic acid and curcumin enriched dietetic formulation reduces the growth of inherited intestinal polyps in an animal model.
Girardi B; Pricci M; Giorgio F; Piazzolla M; Iannone A; Losurdo G; Principi M; Barone M; Ierardi E; Di Leo A
World J Gastroenterol; 2020 Apr; 26(14):1601-1612. PubMed ID: 32327909
[TBL] [Abstract][Full Text] [Related]
17. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
Li Q; Ishikawa TO; Oshima M; Taketo MM
Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
[TBL] [Abstract][Full Text] [Related]
18. Chemopreventive effects of silymarin and silibinin on N-butyl-N-(4-hydroxybutyl) nitrosamine induced urinary bladder carcinogenesis in male ICR mice.
Tyagi A; Raina K; Singh RP; Gu M; Agarwal C; Harrison G; Glode LM; Agarwal R
Mol Cancer Ther; 2007 Dec; 6(12 Pt 1):3248-55. PubMed ID: 18089718
[TBL] [Abstract][Full Text] [Related]
19. A targeted constitutive mutation in the APC tumor suppressor gene underlies mammary but not intestinal tumorigenesis.
Gaspar C; Franken P; Molenaar L; Breukel C; van der Valk M; Smits R; Fodde R
PLoS Genet; 2009 Jul; 5(7):e1000547. PubMed ID: 19578404
[TBL] [Abstract][Full Text] [Related]
20. Transforming activity and therapeutic targeting of C-terminal-binding protein 2 in Apc-mutated neoplasia.
Sumner ET; Chawla AT; Cororaton AD; Koblinski JE; Kovi RC; Love IM; Szomju BB; Korwar S; Ellis KC; Grossman SR
Oncogene; 2017 Aug; 36(33):4810-4816. PubMed ID: 28414304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
